Financial Services

A new report reveals supporting family caregivers isn't just compassionate—it's a financially sound strategy for hospitals to cut costs and improve care.

Steel giant Nucor announces a massive new share repurchase and its 212th straight dividend, signaling deep confidence in its future and the broader economy.

The acclaimed Eagan eatery expands to Golden Valley, bringing its famous menu and a new lunch service while honoring the legacy of the former Mort's Deli.

The bakery giant announced its 94th straight quarterly dividend, but a weak 2026 forecast and high payout ratio raise questions about its sustainability.

New data on leronlimab reveals striking long-term survival signals in heavily pretreated mTNBC patients, hinting at a new way to fight the disease.

Despite a reported net loss, the REIT saw a 162% jump in key operational funds and a 22% surge in its senior housing portfolio's income.

New data reveals a targeted therapy can help patients with a rare, aggressive lung cancer even after their disease shows signs of worsening.

A new virotherapy platform delivers a one-two punch of a T-cell activator and a BiTE, aiming to overcome historical failures in solid tumor therapy.

With a 10x surge in transaction volume, Pay Protocol's success on TRON highlights a quiet revolution in business finance, powered by stablecoins.

With its Felix AI assistant, Syncx is accelerating locums staffing with faster placements and risk assessment to combat a critical healthcare shortage.

Cricket icon Rahul Dravid and Colgate Total are reframing oral care from simple hygiene to a critical performance ritual backed by compelling science.

As a historic cold snap gripped New York, renewable diesel kept essential city services running, proving its reliability in the most extreme conditions.

After selling its wireless unit, TDS reports soaring profits and announces aggressive new growth targets for its fiber broadband and tower businesses.

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

The biotech firm landed $1M at a premium, a sign of investor faith. But with past regulatory hurdles, can this cash pave a new path for its NurOwn® therapy?

Norsemont Mining's initial Phase 3 drilling at Choquelimpie reveals promising geology, but the annual Altiplano Winter forces a temporary halt.

A new partnership will supply Japan's surging cell therapy sector with critical, GMP-grade materials, aiming to accelerate the path from lab to clinic.

Balmain Beauty unveils Destin de Balmain. We explore the strategy, sustainability, and Parisian style behind the much-anticipated luxury fragrance launch.

The iBuying giant reports faster sales and record margins for new home buys, signaling its turnaround plan may finally be taking hold.

A federal court ruling against Corcept Therapeutics clears a key legal hurdle for Teva's generic Cushing's syndrome drug, rattling investors.